Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

199 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

Eligibility End Stage Renal Disease NCT00131872

- 20.09.21 - 1 Formular, 2 Itemgruppen, 16 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access Grafts; ODM derived from: https://clinicaltrials.gov/show/NCT00131872

Eligibility Chronic Kidney Disease NCT00974532

- 20.09.21 - 1 Formular, 2 Itemgruppen, 13 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Analysis of Calcium Balance in Chronic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00974532

Eligibility Chronic Kidney Disease NCT00548249

- 20.09.21 - 1 Formular, 2 Itemgruppen, 25 Datenelemente, 1 Sprache
Itemgruppen: Criteria, Exclusion Criteria
Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis; ODM derived from: https://clinicaltrials.gov/show/NCT00548249

Eligibility Chronic Kidney Disease NCT00704678

- 20.09.21 - 1 Formular, 2 Itemgruppen, 13 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis; ODM derived from: https://clinicaltrials.gov/show/NCT00704678

Eligibility Chronic Kidney Disease NCT00764816

- 20.09.21 - 1 Formular, 2 Itemgruppen, 11 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Effect of Dietary Protein Source on Phosphaturia, PTH and FGF23 in Patients With CKD 3 and 4; ODM derived from: https://clinicaltrials.gov/show/NCT00764816

Eligibility Kidney, Polycystic, Autosomal Dominant NCT00890279

- 20.09.21 - 1 Formular, 2 Itemgruppen, 13 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD); ODM derived from: https://clinicaltrials.gov/show/NCT00890279

Eligibility End-stage Renal Disease NCT01435174

- 20.09.21 - 1 Formular, 2 Itemgruppen, 18 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01435174

Eligibility Renal Cell Carcinoma NCT00610389

- 20.09.21 - 1 Formular, 2 Itemgruppen, 11 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT00610389

Eligibility End-Stage Renal Disease NCT02392208

- 20.09.21 - 1 Formular, 2 Itemgruppen, 20 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5; ODM derived from: https://clinicaltrials.gov/show/NCT02392208

Eligibility Renal Diseases NCT00645437

- 20.09.21 - 1 Formular, 2 Itemgruppen, 18 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
A Study to Evaluate the Pharmacokinetics and Safety of Levofloxacin in Patients With Varying Degrees of Renal Function.; ODM derived from: https://clinicaltrials.gov/show/NCT00645437

Eligibility Chronic Kidney Disease NCT00368017

- 20.09.21 - 1 Formular, 2 Itemgruppen, 14 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Metabolic Effects of Thiazolidinediones in Chronic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00368017

Eligibility End-stage Renal Disease NCT00586131

- 02.09.21 - 1 Formular, 2 Itemgruppen, 22 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Arterial pH and N-balances in APD; ODM derived from: https://clinicaltrials.gov/show/NCT00586131

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video